Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Escitalopram and Sertraline Population Pharmacokinetic Analysis in Pediatric Patients.

Clinical pharmacokinetics - 1 Nov 2023

Poweleit Ethan A, Taylor Zachary L, Mizuno Tomoyuki, Vaughn Samuel E, Desta Zeruesenay, Strawn Jeffrey R, Ramsey Laura B

Abstract excerpt

BACKGROUND AND OBJECTIVE: Escitalopram and sertraline are commonly prescribed for anxiety and depressive disorders in children and adolescents. The pharmacokinetics (PK) of these medications have been evaluated in adults and demonstrate extensive variability, but studies in pediatric patients are limited. Therefore, we performed a population PK analysis for escitalopram and sertraline in children and adolescents...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Child
Share to Cytochrome P-450 CYP2C19

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phenotype

Source

Open in PubMed Open full text

Identifiers

PMID: 37755681
DOI: 10.1007/s40262-023-01294-8
PMCID: PMC11003701

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Escitalopram and Sertraline Population Pharmacokinetic Analysis in Pediatric Patients.PMID 37755681Read ↗

Pharmacogenetics to Predict Adverse Events Associated With Antidepressants.Semantic proximity Read ↗

Sertraline dosing trends in children and adolescents stratified by CYP2C19 genotype.Semantic proximity Read ↗

Pharmacogenetics of Sertraline Tolerability and Response in Pediatric Anxiety and Depressive DisordersSemantic proximity Read ↗

Effect of age, weight, and CYP2C19 genotype on escitalopram exposure.Semantic proximity Read ↗

Population Pharmacokinetics of Stiripentol in Paediatric Patients with Dravet Syndrome Treated with Stiripentol, Valproate and Clobazam Combination Therapy.Semantic proximity Read ↗

Impact of CYP2C19 Phenotype on Escitalopram Response in Geriatrics: Based on Physiologically-Based Pharmacokinetic Modeling and Clinical Observation.Semantic proximity Read ↗

Escitalopram Personalized Dosing: A Population Pharmacokinetics Repository Method.Semantic proximity Read ↗

Clinical pharmacokinetics of antipsychotics in pediatric populations: a scoping review focusing on dosing regimen.Semantic proximity Read ↗

Escitalopram population pharmacokinetics and remedial strategies based on CYP2C19 phenotype.Semantic proximity Read ↗

Pharmacogenetic Factors Influence Escitalopram Pharmacokinetics and Adverse Events in Youth with a Family History of Bipolar Disorder: A Preliminary Study.Semantic proximity Read ↗

The application of precision dosing in the use of sertraline throughout pregnancy for poor and ultrarapid metabolizer CYP 2C19 subjects: A virtual clinical trial pharmacokinetics study.Semantic proximity Read ↗

Effect of Individual and Combined Cytochrome P450 Activity Scores on Symptom Improvement and Side Effects in Youth Treated With Sertraline.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.